Government pricing compliance is one of the highest-stakes challenges in life sciences.
Errors in Medicaid Best Price, AMP, or 340B calculations don’t stay contained. They compound into retroactive rebate exposure, regulatory scrutiny, and the kind of late-stage surprises that erode trust in your revenue numbers.
For growing pharma organizations, the risk usually isn’t a lack of expertise. It’s infrastructure: spreadsheets standing in for systems, calculations that live with one person instead of one process, and manual workarounds that quietly become “how we’ve always done it.”
This checklist walks through four areas where government pricing risk hides in plain sight:
- CMS & Medicaid Compliance — AMP, Best Price, URA, and restatement controls
- VA / Federal Supply Schedule — Non-FAMP, FCP, Big 4 pricing, and CSP disclosures
- State Price Transparency — WAC notices, annual filings, and cost justification
- Data Integrity & Operational Controls — the system-of-record question that sits underneath all three
What’s Inside
A practical, section-by-section audit of your current process
Each section is built around the same question: if a regulator asked you to prove this today, could you?
✓ 20+ checklist items scored by risk level (High / Medium / Low) ✓ Plain-language explanations of why each gap matters — not just compliance jargon ✓ A scoring guide to help you prioritize what to fix first ✓ A notes column to assign owners and timelines as you work through it with your team
This isn’t a generic compliance form. It’s built around how revenue actually breaks down for growing pharma organizations, where pricing, contracting, and finance hand off work to each other, and where those handoffs create risk.
You don’t need enterprise complexity to be audit-ready.
Right-sized revenue management means accuracy without overengineering, automated calculations, a single system of record, and controls that scale with you rather than slowing you down. That’s the thinking behind this checklist, and it’s the thinking behind iContracts.
This checklist is provided for informational purposes and does not constitute legal or regulatory advice.
